Advertisement
AVTX vs XBIT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a StrongBuy and XBIT is a Buy.
AVTX in +9.65% Uptrend, growing for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AVTX advanced for three days, in 199 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AVTX's RSI Indicator exited the oversold zone, 31 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on AVTX as a result. In 66 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for AVTX just turned positive on November 06, 2026. Looking at past instances where AVTX's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for AVTX moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
AVTX broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AVTX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. AVTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.828) is normal, around the industry mean (3.498). P/E Ratio (-1.571) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (19.030) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. AVTX's P/S Ratio (10000.000) is very high in comparison to the industry average of (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
XBIT's RSI Oscillator ascends from oversold territory
The RSI Indicator for XBIT moved out of oversold territory on October 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 25 of the 32 cases the stock moved higher. This puts the odds of a move higher at 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 70 cases where XBIT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for XBIT just turned positive on November 09, 2026. Looking at past instances where XBIT's MACD turned positive, the stock continued to rise in 37 of 56 cases over the following month. The odds of a continued upward trend are 66%.
Following a +4.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where XBIT advanced for three days, in 131 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
XBIT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XBIT as a result. In 88 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
XBIT moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XBIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for XBIT entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.449) is normal, around the industry mean (3.498). P/E Ratio (-1.277) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (5.228) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. XBIT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XBIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
AVTX | XBIT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 2 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 73 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 97 | |
PRICE GROWTH RATING 1..100 | 93 | 74 | |
P/E GROWTH RATING 1..100 | 8 | 25 | |
SEASONALITY SCORE 1..100 | 9 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XBIT's Valuation (73) in the Biotechnology industry is in the same range as AVTX (98) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew similarly to AVTX’s over the last 12 months.
XBIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew similarly to AVTX’s over the last 12 months.
XBIT's SMR Rating (97) in the Biotechnology industry is in the same range as AVTX (97) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew similarly to AVTX’s over the last 12 months.
XBIT's Price Growth Rating (74) in the Biotechnology industry is in the same range as AVTX (93) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew similarly to AVTX’s over the last 12 months.
AVTX's P/E Growth Rating (8) in the Pharmaceuticals Other industry is in the same range as XBIT (25) in the Biotechnology industry. This means that AVTX’s stock grew similarly to XBIT’s over the last 12 months.
| AVTX | XBIT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 66% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 70% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 83% |
| Advances ODDS (%) | 3 days ago 87% | 2 days ago 67% |
| Declines ODDS (%) | 7 days ago 88% | 7 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 74% |
| Aroon ODDS (%) | 1 day ago 88% | 3 days ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AVTX’s FA Score shows that 1 FA rating(s) are green while XBIT’s FA Score has 1 green FA rating(s).
- AVTX’s FA Score: 1 green, 4 red.
- XBIT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AVTX’s TA Score shows that 4 TA indicator(s) are bullish while XBIT’s TA Score has 5 bullish TA indicator(s).
- AVTX’s TA Score: 4 bullish, 5 bearish.
- XBIT’s TA Score: 5 bullish, 4 bearish.
Price Growth
AVTX (@Biotechnology) experienced а +20.37% price change this week, while XBIT (@Biotechnology) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
Reported Earning Dates
AVTX is expected to report earnings on Mar 31, 2027.
Industries' Descriptions
@Biotechnology (-0.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AVTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with VYGR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then VYGR could also see price increases.
| Ticker / NAME | Correlation To AVTX | 1D Price Change % | ||
|---|---|---|---|---|
| AVTX | 100% | +18.85% | ||
| VYGR - AVTX | 40% Loosely correlated | -3.56% | ||
| EDIT - AVTX | 38% Loosely correlated | -4.99% | ||
| ARVN - AVTX | 37% Loosely correlated | -0.14% | ||
| FDMT - AVTX | 36% Loosely correlated | +4.25% | ||
| IBIO - AVTX | 36% Loosely correlated | +5.67% | ||
More | ||||
XBIT and
Correlation & Price change
A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with IMNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then IMNM could also see price increases.
| Ticker / NAME | Correlation To XBIT | 1D Price Change % | ||
|---|---|---|---|---|
| XBIT | 100% | -1.02% | ||
| IMNM - XBIT | 35% Loosely correlated | +2.25% | ||
| AXON - XBIT | 34% Loosely correlated | +4.26% | ||
| MGX - XBIT | 30% Poorly correlated | +8.04% | ||
| AVTX - XBIT | 29% Poorly correlated | +18.85% | ||
| KNSA - XBIT | 29% Poorly correlated | +0.78% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMCS | 43.65 | 1.44 | +3.41% |
| Xtrackers MSCI Emerging Markets Select ETF (EMCS) | |||
| VOO | 698.35 | 8.85 | +1.28% |
| Vanguard S&P 500 ETF (VOO) | |||
| CSSD | 24.67 | 0.03 | +0.13% |
| Cohen & Steers Short Duration Preferred and Income Active ETF (CSSD) | |||
| BKFI | 23.11 | N/A | N/A |
| BNY Mellon Active Core Bond ETF (BKFI) | |||
| SPUT | 27.55 | N/A | N/A |
| Innovator Daily PutWrite ETF (SPUT) | |||